MedPath

Essen Technology (Beijing) Co., Ltd.

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization

Not Applicable
Conditions
Ischemic Heart Disease
Myocardial Ischemia
Coronary Artery Lesions,Primary
Coronary Disease
Acute Coronary Syndrome
Furcation Lesion of Coronary Artery
Interventions
Device: Tivoli® DES
Device: Firebird2® DES
First Posted Date
2012-09-07
Last Posted Date
2013-02-21
Lead Sponsor
Essen Technology (Beijing) Co., Ltd.
Target Recruit Count
2790
Registration Number
NCT01681381
Locations
🇨🇳

The General Hospital of Shenyang Military Region, Shenyang, Liaoning, China

© Copyright 2025. All Rights Reserved by MedPath